Annual report pursuant to Section 13 and 15(d)

Supplemental Disclosure of Cash Flow Information

v3.21.1
Supplemental Disclosure of Cash Flow Information
12 Months Ended
Dec. 31, 2020
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information

Note 18 – Supplemental Disclosure of Cash Flow Information

 

    Year Ended December 31,  
    2020     2019  
Cash paid for interest   $ 64,454     $ -  
Cash paid for income taxes   $ -     $ 45,000  
                 
Acquisition of Jellico Community Hospital and CarePlus Center:                
Inventory   $ -     $ 317,427  
Property and equipment     -       500,000  
Intangible assets     -       250,000  
Accrued expenses     -       158,890  
                 
Non-cash investing and financing activities:                
Series I-2 Preferred Stock converted into common stock   $ 277,994     $ 1,268,972  
Issuance of Series M Preferred Stock in exchange for related party loans and accrued interest     22,000,000       -  
Loans and accrued interest exchanged for Series M Preferred Stock     18,849,632       -  
Issuance of Series N Preferred Stock in exchange for debentures, accrued interest and Series I-1 and Series I-2 Preferred Stock     30,435,519       -  
Debentures, accrued interest and Series I-1 and Series I-2 Preferred Stock exchanged for Series N Preferred Stock     19,342,322       -  
Series N Preferred Stock converted into common stock     1,001,000       -  
Deemed dividends from exchanges of debt for preferred stock     6,871,086       -  
Deemed dividends from down-round provisions of warrants and debentures     256,383,632       123,861,587  
Common stock issued in cashless exercise of warrants     -       11,962  
Exchange of Series K Preferred Stock for Series L Preferred Stock     2,500       -  
Issuance of Series L Preferred Stock     2,500       -  
Original issue discounts on debt     122,885       400,000